Eli Lilly and Company (LLY.SW) Stock Overview
Explore Eli Lilly and Company’s financial performance, market position, analyst ratings, and future outlook.
Eli Lilly and Company (LLY.SW)
Key Financials
Key Financials
Market Cap
891.7B
P/E Ratio
41.18
EPS (TTM)
$25.17
ROE
0.93%
LLY.SW Stock Analysis & Investment Overview (SIX)
Our AI-powered analysis of Eli Lilly and Company (SIX: LLY.SW) gives investors deep insight into how the stock performs on the SIX exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Eli Lilly and Company's SIX-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of LLY.SW on the SIX shows an RSI of 62.23, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $937.40 for the SIX listing.
Key metrics behind Eli Lilly and Company's SIX-traded stock include a P/E ratio of 41.18 and a market capitalization of 891.7B. Combined with our AI analysis, these give both institutional and retail investors a clear view of LLY.SW on the SIX.